July 30th 2025
Haller expands her leadership role of ophthalmologist-in-chief following the retirement of longtime executive Joseph P. Bilson.
Study: Thelazia callipaeda infection in a 41-year-old female patient
December 27th 2024A team of researchers in China detail a case of Thelazia callipaeda infection in the right eye of a 41-year-old woman working in an office. The patient presented with persistent foreign body sensation, pruritus, and redness despite initial treatment with polyethylene glycol and levofloxacin eye drops.
Read More
Diagnostic Maze: Navigating the complexity of isolated optic disc edema in syphilitic uveitis
December 10th 2024With cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for timely diagnosis and treatment.
Read More
Study highlights current and potential roles of AI in glaucoma diagnosis
December 7th 2024According to researchers, GPT-4o demonstrates potential in generating comprehensive differential glaucoma diagnoses but falls short in primary diagnostic accuracy, underscoring its role as a complementary tool rather than a standalone diagnostic solution.
Read More
Early vision screening is key to slowing myopia progression in children
November 28th 2024In the wake of a report by a group of researchers in China detailing the increasing prevalence of myopia worldwide, Daniel Cyr, MD, a pediatric ophthalmologist at Stony Brook Medicine, agreed with its assessment, telling Ophthalmology Times he is seeing an increase in pediatric myopia at his clinic in New York.
Read More
Understanding cerebral/cortical visual impairment: New insights and advances in diagnosis
November 22nd 2024Cerebral/cortical visual impairment (CVI) is a leading cause of childhood blindness, caused by brain damage to visual pathways. Researchers are refining its definition and diagnostic methods to improve early detection and treatment, enhancing outcomes for affected children.
Read More
Prevent Blindness declares 5th annual Thyroid Eye Disease Awareness Week
November 15th 2024Prevent Blindness has designated November 18 to 24, 2024, as the 5th annual Thyroid Eye Disease (TED) Awareness Week. The week aims to raise awareness of TED's symptoms, impact on vision and mental health, and new treatment options. Educational resources and expert-led episodes will support patients and healthcare professionals.
Read More
Study examines the use of AI–based detection of diabetic retinopathy in the US
November 13th 2024A recent cohort study revealed low adoption of FDA-approved AI-based diabetic retinopathy detection, with less than 5% of diabetic patients receiving ophthalmic imaging. Researchers emphasize the need for improved awareness, cost-effectiveness, and integration to increase diabetic retinopathy screening rates.
Read More
Noninvasive choroidal vessel analysis using deep learning: A novel approach to OCT angiography
November 11th 2024Peking University researchers have developed a deep learning-based, noninvasive choroidal angiography method that enables detailed 3D visualization of choroidal vessels from OCT scans. This technique could improve diagnostics for retinal diseases like macular degeneration, offering a safer alternative to traditional methods.
Read More
Prevent Blindness recognizes November as Diabetes-Related Eye Disease Awareness Month
November 5th 2024To educate the public—including parents, caregivers, and allied health professionals—Prevent Blindness is offering free educational resources, including fact sheets, social media graphics, web pages, and educational videos in both English and Spanish.
Read More
Paper: Rising diabetic retinopathy rates in youth signal potential public health crisis
October 12th 2024A recent paper reveals increasing rates of diabetic retinopathy in young patients with diabetes, sparking concerns over inadequate screening and management, especially among Black and Hispanic youths.
Read More
Advancing CVI research: NEI initiative and multidisciplinary collaboration
October 7th 2024Lotfi Merabet, OD, PhD, MPH, discusses his role as co-chairman of a National Eye Institute initiative focused on advancing research in cerebral visual impairment (CVI). The initiative's key goals include raising awareness about CVI, establishing clear diagnostic criteria, and developing a national registry to track patients and their conditions over time. CVI, a complex condition that affects how the brain processes visual information, requires a multidisciplinary approach involving not only ophthalmologists and optometrists but also neuroscientists, educators, and rehabilitation specialists.
Watch
EyeCon 2024: New treatments in geographic atrophy from detection to intervention
September 28th 2024Adam S. Wenick, MD, PhD, chaired a symposium on geographic atrophy (GA) at EyeCon 2024, focusing on the diagnosis, monitoring, and FDA-approved treatments for GA. The session with Leonard Messner, OD, FAAO, also included case presentations that highlighted key factors for clinicians to consider when selecting appropriate treatment options.
Watch
EyeCon 2024: Laura Periman, MD, shares a surprising clinical experience with Demodex blepharitis
September 16th 2024Laura M. Periman, MD, shares her passion for dry eye disease, discussing her discovery of the Alpenglow Sign in Demodex blepharitis and her insights on research and education for clinicians. Periman will join the EyeCon 2024 faculty as Honorary Chair.
Watch